Your browser doesn't support javascript.
loading
Poor long-term outcomes despite improved hospital survival for patients with cryptococcal meningitis in rural, Northern Uganda.
Okwir, Mark; Link, Abigail; Opio, Bosco; Okello, Fred; Nakato, Ritah; Nabongo, Betty; Alal, Jimmy; Rhein, Joshua; Meya, David; Liu, Yu; Bohjanen, Paul R.
Affiliation
  • Okwir M; Department of Public Health Sciences, University of Rochester Medical Center, Rochester, New York, United States of America.
  • Link A; Department of Internal Medicine, Faculty of Medicine, Lira University, Lira, Uganda.
  • Opio B; Department of Medicine, Lira Regional Referral Hospital, Lira, Uganda.
  • Okello F; School of Nursing, University of Washington, Seattle, Washington, United States of America.
  • Nakato R; Department of Medicine, Division of Infectious Diseases, University of Rochester, Rochester, New York, United States of America.
  • Nabongo B; Department of Internal Medicine, Faculty of Medicine, Lira University, Lira, Uganda.
  • Alal J; Department of Medicine, Lira Regional Referral Hospital, Lira, Uganda.
  • Rhein J; Department of Internal Medicine, Faculty of Medicine, Lira University, Lira, Uganda.
  • Meya D; Department of Medicine, Lira Regional Referral Hospital, Lira, Uganda.
  • Liu Y; Department of Medicine, Lira Regional Referral Hospital, Lira, Uganda.
  • Bohjanen PR; Department of Medicine, Lira Regional Referral Hospital, Lira, Uganda.
PLoS One ; 19(5): e0303805, 2024.
Article in En | MEDLINE | ID: mdl-38771769
ABSTRACT

BACKGROUND:

Cryptococcal meningitis (CM) remains a major cause of death among people living with HIV in rural sub-Saharan Africa. We previously reported that a CM diagnosis and treatment program (CM-DTP) improved hospital survival for CM patients in rural, northern Uganda. This study aimed to evaluate the impact on long-term survival.

METHODS:

We conducted a retrospective study at Lira Regional Referral Hospital in Uganda evaluating long-term survival (≥1 year) of CM patients diagnosed after CM-DTP initiation (February 2017-September 2021). We compared with a baseline historical group of CM patients before CM-DTP implementation (January 2015-February 2017). Using Cox proportional hazards models, we assessed time-to-death in these groups, adjusting for confounders.

RESULTS:

We identified 318 CM patients, 105 in the Historical Group, and 213 in the CM-DTP Group. The Historical Group had a higher 30-day mortality of 78.5% compared to 42.2% in the CM-DTP Group. The overall survival rate for the CM-DTP group at three years was 25.6%. Attendance at follow-up visits (HR0.13, 95% CI [0.03-0.53], p <0.001), ART adherence (HR0.27, 95% CI [0.10-0.71], p = 0.008), and fluconazole adherence (HR0.03, 95% CI [0.01-0.13], p <0.001), weight >50kg (HR0.54, 95% CI [0.35-0.84], p = 0.006), and performance of therapeutic lumbar punctures (HR0.42, 95% CI [0.24-0.71], p = 0.001), were associated with lower risk of death. Altered mentation was associated with increased death risk (HR 1.63, 95% CI 1.10-2.42, p = 0.016).

CONCLUSION:

Long-term survival of CM patients improved after the initiation of the CM-DTP. Despite this improved survival, long-term outcomes remained sub-optimal, suggesting that further work is needed to enhance long-term survival.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Rural Population / Meningitis, Cryptococcal Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Year: 2024 Type: Article

Full text: 1 Database: MEDLINE Main subject: Rural Population / Meningitis, Cryptococcal Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Year: 2024 Type: Article